Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
In this webinar we will take a practical approach with a Phase-3 trial as an example case study to evaluate the usefulness of modern tools and methodologies. We will investigate what role Artificial Intelligence and Machine Learning (AI/ML) tools can play, what role modern trial design tools and methodologies can play and how trials can be effectively monitored for proactive planning and efficient project management. We will hear clinical, AI/ML and biostatistics perspective to understand how a multidisciplinary team can help run an efficient and effective trial
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Use machine learning-driven analytics to help identify promising patient subgroups, potentially preserving your investment and ensuring valuable therapies reach patients.